FDA 483 - Bracco Diagnostics, Inc. - November 27, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Bracco Diagnostics, Inc. in Princeton, NJ was inspected from November 20-27, 2024. The inspection revealed significant deficiencies in the firm's adverse drug experience reporting system, including the untimely submission of over 30 serious and unexpected individual case safety reports to the FDA. Additionally, the firm lacked adequate written procedures for post-marketing adverse drug experience reporting, and existing procedures for Periodic Adverse Drug Experience Reports (PADERs) were found to be incorrect or incomplete.
ID · dac0dc40-437f-417a-b194-d7f4fa540d18